Dr. Nahid Razi, received her Ph.D. in Medicinal Sciences in 1995, from Uppsala University in Sweden, where she worked on biosynthesis of complex carbohydrates with Professor Ulf Lindahl, a Nobel Prize committee member. During her post-doctoral program in Cancer Center at the University of California in San Diego (UCSD), Razi discovered a new mechanism of glycan-mediated cell signaling in immune cells activation.

 

In 2001, Razi joined the Consortium for Functional Glycomics (CFG) at The Scripps Research Institute (TSRI-La Jolla). The CFG was a governmental-funded initiative for developing technologies to advance the global research in glycoscience. Dr. Razi was recruited as a team leader for developing a library of recombinant glyco-enzymes for chemo-enzymatic synthesis of glycans. She then served as the director of the glycan-microarray facility till September 2011, when her group successfully accomplished their major objective and launched the world’s largest and most diverse mammalian glycan-microarray. The CFG glycan microarray is a valuable technique that has remained useful to the science community for studying glycan-mediated activities.

 

Dr. Razi established AccuDava, Inc. in 2006, to pursue her independent investigations on personalized cancer chemotherapy, as a part-time effort. This study was based on Razi’s discovery of the cell-surface glycan biomarkers for drug response in standard chemotherapy with platinum-based drugs.

 

Since 2011, Razi has put her full efforts at AccuDava, Inc. for clinical validation of two prognostic tests she has developed for platinum-drug response.  Platinum-drugs are the most common anti-cancer drugs used in treatments of various cancers such as testis, ovarian, lung, head and neck, and several other cancer types. Razi dedicated her tireless efforts on this project to the memory of her friend, who passed away in 2008, after six months suffering from ineffective chemotherapy with platinum drugs.



Academic Merit

Ph. D. - Medical sciences- Uppsala University, Sweden (1995)

Post-doctoral - Hematology-Oncology, Cancer Center- University of California in San Diego,  (UCSD)

Ph. D. candidate-Biochemistry- University of Iowa, USA  

 


Professional Experience

2006-present  Director, AccuDava Inc. La Jolla, CA

2007-2011      Director, Glycan-Microarray facility, The Scripps  Research Institute (TSRI), La Jolla, CA

2001- 2007     Co-director, protein production and carbohydrate synthesis Core  facility, The Scripps Research Institute (TSRI), CA

2000-2001      Senior scientist, Dept. of surgery, UCSD, La Jolla, CA

1998-2000      Research director, Paik-Inje Memorial Inst., San Diego, CA

1997-1998      Research associate, Cancer center, UCSD, La Jolla, CA

 


Patents

2013- Methods and Systems for Predicting Drug response. Pending.

2009- Methods for Detecting Multi-drug Resistance- Issued - UPO

1993 - "Anticoagulants and processes for preparing such" - EPO

 


Awards and Scholarships

2006 Grant Award: "Polysaccharide Research AB", Sweden

2001 Grant Award: ”National Heart, Lung & Blood Inst”, USA

1998 Grant Award: "California Cancer Research Program", USA

1997 Grant Award: "Cure for Lymphoma Foundation", USA

1995 Grant Award: "Polysaccharide Research AB", Sweden

1990 Scholarship: “Uppsala University”, Sweden

 


Research and Development

Identified cell surface “Biomarkers” for predicting chemo-sensitivity and chemo  resistance in conventional cancer chemotherapy.

Developed clinical assays for biomarker detection on human cancer specimens.

Investigated a novel mechanism of drug uptake in cancer cells.

Developed an enzyme library containing 35 recombinant enzymes for chemo- enzymatic synthesis of cell surface glycans.

Developed and launched the world’s largest glycan microarray, which mimics the mammalian cell membrane.

Identified a glycan-mediated mechanism in lymphocytes activation.

Synthesized a heparin-like anticoagulant drug, on E. coli-K5 capsular polysaccharide precursor.

 


Invited Book Chapters

Wenjie Peng, Corwin M. Nycholat and Nahid Razi (2013). Glycan Microarray Screening Assay for Glycosyltransferases Specificities.

In Glycosyltransferases. Methods in Molecular Biology, Humana Press, Springer Science, In press.

 

Ola Blixt and Nahid Razi (2008). Enzymatic Synthesis with Glycosyltransferases. In Glycoscience, Chemistry and Chemical Biology, Ed. B. Fraser-Reid,

Springer-Verlag BerlinHeidelberg New York.

 

Ola Blixt and Nahid Razi (2006). Chemoenzymatic Synthesis of Glycan Libraries. In Methods Enzymol. 415, 137-53


Blixt, O, and Razi, N (2004). Strategies for Synthesis of an Oligosaccharide Library Using a Chemo-Enzymatic Approach

Synthesis of Carbohydrate Through Biotechnology. In ACS Symposium series 873. P.G. Wang and Y. Ichikawa 93-112

 

SELECTED PUBLICATIONS